medigraphic.com
ISSN 2954-3835 (Electronic)
ISSN 2683-2828 (Print)

2020, Number S3

<< Back Next >>

Cardiovasc Metab Sci 2020; 31 (S3)

COVID-19 and the renin, angiotensin, aldosterone system. A complex relationship

Díaz-Barreiro LA, Cossio-Aranda J, Verdejo-Paris J, Odín-De los Ríos M, Galván-Oseguera H, Álvarez-López H, Alcocer-Gamba MA

Language: Spanish
References: 31
Page: 182-189
PDF size: 204.16 Kb.


ABSTRACT

The COVID-19 pandemic has had major negative health, psychological, social and economic repercussions for individuals, families, communities, countries and for humanity in general. The interrelation with age and the presence of chronic non-communicable diseases (hypertension, diabetes, obesity, smoking) seems to go further than what would be explained by the prevalence and distribution of both. The drugs that act on the renin-angiotensin-aldosterone system are in many cases the backbone for the management of these diseases, it has been known for a long time that these drugs significantly increase the expression of receptors for angiotensin conversion enzyme type 2 in the lung tissue. This fact, together with the knowledge that the route of entry of the virus into the cell is precisely the ACE-2 receptor, initiated a hypothesis, based on very low-quality evidence, which quickly became generalized in the media, that the use of these drugs could be negative and that they should be interrupted immediately. The response of practically all Scientific Societies was almost immediate, with the precise indication that treatment with these drugs should not be discontinued, since the evidence of their usefulness is based on very solid and high-quality evidence. Simultaneously, a different hypothesis also appeared, also based on very preliminary evidence, that these drugs are not only harmful but also beneficial, however these medicaments are not yet accepted as agents for the prevention or treatment of this disease or its complications. This review reports current knowledge on the relationship between COVID-19 and SRAA.


REFERENCES

  1. Wan Y, Shang J, Graham R, Baric RS, Li F. Receptor recognition by the novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS coronavirus. J Virol. 2020; 94 (7): e00127-20. doi: 10.1128/JVI.00127-20.

  2. Sparks MA, Hiremath S et al. The coronavirus conundrum: ACE2 and hypertension edition. NephJC. [Accessed 5 Apr 2020] Available in: https://www.nephjc.com/news/covidace2.

  3. Esler M, Esler D. Can angiotensin receptor-blocking drugs perhaps be harmful in the COVID-19 pandemic? J Hypertens. 2020; 38 (5): 781-782. doi: 10.1097/HJH.0000000000002450.

  4. https://www.dailymail.co.uk/news/article-8108735/Medicines-hi-gh-blood-pressure-diabetes-worsen-coronavirus-symptoms.html [Revisada 14 abril 2020]

  5. Karram T, Abbasi A, Keidar S, Golomb E, Hochberg I, Winaver J et al. Effects of spironolactone and eprosartan on cardiac remodeling and angiotensin-converting enzyme isoforms in rats with experimental heart failure. Am J Physiol Heart Circ Physiol. 2005; 289: H1351–H1358.

  6. Chappell MC, Marshall AC, Alzayadneh EM, Shaltout HA, Diz DI. Update on the ACE2-Angiotensin-(1-7)-MAS receptor axis. Front Endocrinol. 2014; 4: 201-215.

  7. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020; 382: 727-733.

  8. Wrapp D, Wang N, Corbett KS, Goldsmith JA, Hsieh CL, Abiona O et al. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science. 2020; 367: 1260-1263.

  9. Whu N, Zhang D, Wang W, Li X, Yang B, Song J et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020; 382: 727-733.

  10. Wan Y, Shang J, Graham R, Baric RS, Li F. Receptor recognition by the novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS coronavirus. J Virol. 2020; 94 (7): e00127-20. doi: 10.1128/JVI.00127-20.

  11. Gutierrez F, Masia M, Mirete C, Soldan B, Rodriguez JC, Padilla S et al. The influence of age and gender on the population based incidence of community-acquired pneumonia caused by different microbial pathogens. J Infect. 2006; 53: 166-174.

  12. Ferrario CM, Jessup J, Chappell MC, Averill DB, Brosnihan KB, Tallant EA et al. Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2. Circulation. 2005; 111: 2605-2610.

  13. Meng J, Xiao G, Zhang J, He X, Ou M, Bi J et al. Renin-angiotensin system inhibitors improve the clinical outcomes of COVID-19 patients with hypertension. Emerg Microbes Infect. 2020; 9 (1): 757-760.

  14. Sun ML, Yang JM, Sun YP, Su GH. Inhibitors of RAS might be a good choice for the therapy of COVID-19 pneumonia. Zhonghua Jie He He Hu Xi Za Zhi. 2020; 43: 219-222.

  15. Kuba K, Imai Y, Rao S, Gao H, Guo F, Guan B et al. A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury. Nat Med. 2005; 11: 875-879.

  16. Battistoni A, Volpe M. Might renin-angiotensin system blockers play a role in the COVID-19 pandemic? [published online ahead of print, 2020 Apr 14]. Eur Heart J Cardiovasc Pharmacother. 2020. doi: 10.1093/ehjcvp/pvaa030.

  17. https://www.eshonline.org/spotlights/esh-stabtement-on-covid-19-2/. [Consultada 14 abril 2020]

  18. https://www.escardio.org/Councils/Council-on-Hypertension-(CHT)/News/position-statement-of-the-esc-council-onhypertension-on-ace-inhibitors-and-ang. [Consultada 14 abril 2020]

  19. https://joel-topf-1vjl.squarespace.com/config/. [Consultada 14 abril 2020]

  20. https://www.ccs.ca/images/Images_2020/CCS_CHFS_Update_COVID_CV_medications_Mar20.pdf. [Consultada 14 abril 2020]

  21. International Society of Hypertension (https://renal.org/covid-19/checklist-renal-services-respect-covid-19-pandemic/), (https://ish-world.com/news/a/A-statement-from-the-International-Society-of-Hypertension-on-COVID-19/) [Consultada 14 abril 2020]

  22. https://ish-world.com/news/a/A-statement-from-the-International-Society-of-Hypertension-on-COVID-19/ [Consultada 14 abril 2020]

  23. https://assets.acponline.org/coronavirus/scormcontent/?_ga=2.70091792.1486472653.1584392833-1102360168.1584392833#/ [Consultada 14 abril 2020]

  24. https://www.seh-lelha.org/covid-19/ [Consultada 14 abril 2020]

  25. https://newsroom.heart.org/news/patients-taking-ace-i-and-arbs-who- contract-covid-19-should-continue-treatment-unless-otherwise-advised-by-theirphysician#.XnDMEt7Ot9I.twitter [Consultada 14 abril 2020]

  26. https://www.era-edta.org/en/covid-19-news-and-information/#toggl e-id-1 [Consultada 14 abril 2020]

  27. https://www.hbprca.com.au/wp-content/uploads/2020/03/HBPRCA-Statement-on-COVID-19-and-BP-medication-17.03.20.pdf [Consultada 14 abril 2020]

  28. https://www.whleague.org/index.php/2014-07-09-22-47-11/covid-19-hypertensionguidance. (30 March 2020) [Consultada 14 abril 2020]

  29. https://diabetessociety.com.au/downloads/20200329%20ADS%20Letter%20re%20COVID-19%20and%20Diabetes%20HPs%2029032020_Update%20.pdf [Consultada 14 abril 2020]

  30. https://ampac.org.mx/wp-content/uploads/2020/04/COMUNICAD-GRETHA-SOBRE-LA-RELACIOi%CC%80N-ENTRE-COVID.pdf.pdf.pdf.pdf [Consultada 14 abril 2020]

  31. https://ancam.org.mx/#/comunicados/2-covid-19 [Consultada 14 abril 2020]




2020     |     www.medigraphic.com